Although the survival rates for many types of cancer have improved significantly in recent years, cancer was still responsible for 8.8 million deaths worldwide in 2015, or nearly one in six of all dea
Pharmaceuticals CerRx Inc. Childrens Hospital Los Angeles John Wayne Cancer Institute National Institutes of Health CerRx gets exclusive cancer rights from non-profits April —Oncology start-up CerRx
In Vitro Diagnostics CytoCore Inc. University Hospitals of Cleveland CytoCore licenses biomarker from Univ. Hospitals of Cleveland Feb. —Cancer diagnostics company CytoCore has licensed from the U
Twenty-three antigens can't be wrong 5931 Darwin Court Carlsbad, CA 92008 Phone: (760) 494-4200 Fax: (760) 431-9980 E-Mail/Web Site: dhale@cancervax.com Contact: David Hale, president and CEO Indus